Traditional Medicines Market in the US to 2014 (OTC Healthcare)

Introduction

Traditional Medicines Market in the US to 2014 (OTC Healthcare) is a comprehensive resource for market and segment level data on value from 2004 to 2014 and market/company shares for 2008-09.This report also provides data on key distribution channels and reveals the leading companies in the US traditional medicines market.

Features and Benefits

• Identify key market segments by analyzing market size data on value for categories
• Design business strategies by gaining insight into quantitative market trends over 2004-09 and expectations for 2010-14
• Identify key companies in the traditional medicines market in the US and design M&A strategies by analyzing market share data


Highlights

•The traditional medicines market in the US increased at a compound annual growth rate of 5.1% between 2004 and 2009.
•Leading player in traditional medicines market in the US is GlaxoSmithKline Plc.


Key questions answered

• Which will be the fastest growing segment within the traditional medicines market in the US?
• How will the forecast growth differ from the historic growth exhibited by the traditional medicines market in the US?
• Which company accounted for the largest share of the US traditional medicines market in 2009?

[Studien Infos ausblenden]

TABLE OF CONTENTS
Chapter 1 Executive Summary 2
Summary category level: traditional medicines 2
Chapter 2 Definition 3
Chapter 3 Category Analysis: Traditional Medicines 8
Value analysis (US Dollar), 2004?09 8
Value analysis (US Dollar), 2009?14 9
Company and brand share analysis 10
Distribution analysis 12
Chapter 4 Macroeconomic Profile 14
Macroeconomic Indicators 14
Chapter 5 Research Methodology 19
Methodology overview 19
Secondary research 20
Market modeling 21
Creating an initial data model 21
Revising the initial data model 21
Creating a final estimate 22
Creating demographic value splits 22
Primary research 22
Data finalization 23
Ongoing research 23

LIST OF FIGURES
Figure 1: Traditional medicines, US, value ($m), 2004?14 9
Figure 2: Traditional medicines, US, distribution channels by value (%), 2008?09 13
Figure 3: Annual data review process 20

LIST OF TABLES
Table 1: Traditional medicines category definitions 3
Table 2: Traditional medicines distribution channels 4
Table 3: Traditional medicines, US, value ($m), 2004?09 8
Table 4: Traditional medicines, US, value forecast ($m), 2009?14 9
Table 5: Traditional medicines, US, brand share by value (%), 2008?09 10
Table 6: Traditional medicines, US, value by brand ($m), 2008?09 10
Table 7: Traditional medicines, US, company share by value (%), 2008?09 11
Table 8: Traditional medicines, US, value by company ($m), 2008?09 11
Table 9: Traditional medicines, US, distribution channels by value (%), 2008?09 12
Table 10: Traditional medicines, US, value by distribution channel ($m), 2008?09 12
Table 11: US population, by age group, 2004?09 (millions) 14
Table 12: US population forecast, by age group, 2009?14 (millions) 15
Table 13: US population, by gender, 2004?09 (millions) 15
Table 14: US population forecast, by gender, 2009?14 (millions) 16
Table 15: US nominal GDP, 2004?09 ($bn, nominal prices) 16
Table 16: US nominal GDP forecast, 2009?14 ($bn, nominal prices) 16
Table 17: US real GDP, 2004?09 ($bn, 2000 prices) 17
Table 18: US real GDP forecast, 2009?14 ($bn, 2000 prices) 17
Table 19: US consumer price index, 2004?09 (2000=100) 18
Table 20: US consumer price index, 2009?14 (2000=100) 18


[Inhaltsverzeichnis ausblenden]